SciSparc (SciSparc) EBIT per Share : $-2.55 (TTM As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is SciSparc EBIT per Share?

SciSparc's EBIT per Share for the six months ended in Dec. 2023 was $-1.66. Its EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $-2.55.

During the past 3 years, the average EBIT per Share Growth Rate was -12.30% per year. During the past 5 years, the average EBIT per Share Growth Rate was -105.70% per year. During the past 10 years, the average EBIT per Share Growth Rate was -103.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for SciSparc's EBIT per Share or its related term are showing as below:

SPRCY' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -484 Med: -101.1 Max: 49.3
Current: -12.3

During the past 12 years, the highest 3-Year average EBIT per Share Growth Rate of SciSparc was 49.30% per year. The lowest was -484.00% per year. And the median was -101.10% per year.

SPRCY's 3-Year EBIT Growth Rate is ranked worse than
68.19% of 1311 companies
in the Biotechnology industry
Industry Median: 3.7 vs SPRCY: -12.30

SciSparc's EBIT for the six months ended in Dec. 2023 was $-3.81 Mil.

SciSparc EBIT per Share Historical Data

The historical data trend for SciSparc's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SciSparc EBIT per Share Chart

SciSparc Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT per Share

Get a 7-Day Free Trial

-64.12

-3.39

-5.57

-1.11

-2.54

SciSparc Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT per Share	Get a 7-Day Free Trial															-1.37	-2.11	1.01	-0.89	-1.66

SciSparc EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

SciSparc's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-5.852	/	2.3
=	-2.54

SciSparc's EBIT per Share for the quarter that ended in Dec. 2023 is calculated as

	EBIT per Share		(Q: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-3.81	/	2.3
=	-1.66

EBIT per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-2.55

SciSparc (OTCPK:SPRCY) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

SciSparc EBIT per Share Related Terms

Thank you for viewing the detailed overview of SciSparc's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

SciSparc (SciSparc) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SciSparc Ltd (OTCPK:SPRCY) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

SPRC:USA

Address

20 Raul Wallenberg Street, Tower A, 2nd Floor, Tel Aviv, ISR, 6971916

Website

https://www.scisparc.com

SciSparc Ltd is a specialty clinical-stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company operates in the single segment of the Development of drugs based on cannabinoid molecules to be approved by an official regulatory authority.